Ayşe Nur YÜCEYAR

Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Anabilim Dalı

Araştırma alanları: Sağlık Bilimleri, Tıp, Dahili Tıp Bilimleri, Nöroloji, Temel Bilimler, Yaşam Bilimleri, Cerrahi Tıp Bilimleri, Fizyoterapi ve Rehabilitasyon, Fiziksel Tıp ve Rehabilitasyon, Hemşirelik

Yayınlar

• Modifier-Sensitive Phenotypic Divergence in XMEN Disease (MAGT1 Deficiency): Neurodegenerative and Hematologic Trajectories (2026)
• Exploring the Type 4 Cerebrospinal Fluid Oligoclonal Band Pattern: Clinical and Paraclinical Features with Diagnostic Implications (2026)
• Modifier-Sensitive Phenotypic Divergence in XMEN Disease (MAGT1 Deficiency): Neurodegenerative and Immuno-Hematologic Trajectories (2026)
• Neurogenic Bowel Dysfunction in Multiple Sclerosis: Clinical Determinants and its Association With Bladder Dysfunction in a Multicenter Study (2026)
• Clinical Features, Antibody Profiles, and Prognostic Factors in Autoimmune Encephalitis: A Single-Center Study (2025)
• Clinical Features, Antibody Profiles, and Prognostic Factors in Autoimmune Encephalitis: A Single-Center Study (2025)
• Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish families (2025)
• Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility (P10-1.002) (2025)
• Secondary hypogammaglobulinemia and lymphocytopenia in patients with inflammatory neurological diseases on anti-CD20 therapy: risk of infection and infection-related mortality (2025)
• Effects of dual-task training on balance, gait, dual-task performance, cognitive function, fatigue in individuals with multiple sclerosis: A randomized controlled trial (2025)
• Lower Urinary Tract Symptoms in Male Patients With Multiple Sclerosis: Prevalence and Associations With Quality of Life, Depression, and Anxiety (2025)
• Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report (2025)
• Response to the Letter to the Editor Regarding “Lower Urinary Tract Symptoms in Male Patients With Multiple Sclerosis: Prevalence and Associations With Quality of Life, Depression, and Anxiety” (2025)
• Effect of a gluten-free diet on serum lipopolysaccharide levels and disease progression in multiple sclerosis patients: A 6–month longitudinal study (2025)
• Does physical activity affect urinary incontinence in women with multiple sclerosis? (2025)
• The relationship between severity of overactive bladder symptoms and cognitive dysfunction, anxiety and depression in female patients with multiple sclerosis (2023)
• The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis (2023)
• Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis (2023)
• Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective (2023)
• A Unique Case of Churg–Strauss Syndrome with the Coexistence of Acute Neuropathy and Myositis (2023)
• Exercise Improves Physical Capacity and Promotes Neurotrophic Factors in Patients with Multiple Sclerosis (2022)
• The life balance inventory in patients with multiple sclerosis: Cross-cultural adaptation, reliability and validity of the Turkish version (2022)
• The reliability and validity of the Turkish version of the multiple sclerosis impact scale-29 (2022)
• The relationship between severity of overactive bladder symptoms and cognitive dysfunction, anxiety and depression in female patients with multiple sclerosis (2022)
• Clinical and Demographic Characteristics of 508 Multiple Sclerosis Patients Using Fingolimod (Vintor) Treatment (Two-Year Efficacy and Reliability Data) (2022)
• Multi-center, Randomized, Double-blinded Assessment of TERIFLUNOMIDE (Aubagio®) in Extending the Time to the First Attack in Radiologically Isolated Syndrome: Baseline Characteristics of the TERIS Study. (P5-4.011) (2022)
• Successful rapid drug desensitization to alemtuzumab in a multiple sclerosis patient with severe immediate-type hypersensitivity reaction (2022)
• The Reliability and Validity of the Turkish Version of the Fatigue Assessment Scale in Patients with Multiple Sclerosis (2022)
• Cross-cultural adaptation, reliability and validity of the Turkish version of the Fear of Relapse Scale (FoR) in individuals with multiple sclerosis (2022)
• Cross-cultural adaptation, validation, and the reliability of the Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis (2022)
• Gait assessment in shaped pathways: The test-retest reliability and concurrent validity of the figure of eight test and L test in multiple sclerosis patients without mobility aids (2022)
• The reliability and validity of the 30-second chair stand test and modified four square step test in persons with multiple sclerosis (2022)
• Psychosocial Effects of the Pandemic on MS Patients at a University Hospital Following Patients with Telemedicine, Cross-sectional Study (2022)
• Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression (2022)
• The effect of regular exercise on life quality and cognitive function in patients with multiple sclerosis (2021)
• The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course? (2021)
• Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament and Nitrotyrosine Levels and is Associated with Current Disability in Multiple Sclerosis (2021)
• The comparison of fatigue, sleep quality, physical activity, quality of life, and psychological status in multiple sclerosis patients with or without COVID-19. (2021)
• The comparison of fatigue, sleep quality, physical activity, quality of life, and psychological status in multiple sclerosis patients with or without COVID-19 (2021)
• The reliability and validity of the Turkish version of the telehealth usability questionnaire and the telemedicine satisfaction questionnaire in patients with multiple sclerosis (2021)
• Cross-cultural adaptation, reliability, and validity of the Turkish version of the SymptoMScreen (2021)
• The reliability and validity of the Turkish version of the Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ) and Telemedicine Patient Questionnaire (TPQ) in individuals with multiple sclerosis (2021)
• Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament and Nitrotyrosine Levels and is Associated with Current Disability in Multiple Sclerosis (2020)
• Reliability and validity of the Turkish version of the Multiple Sclerosis Knowledge Questionnaire (2020)
• Adaptation of The Multiple Sclerosis Self-Management Scale into Turkish: A Validity and Reliability Study (2020)
• The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population (2020)
• ADAPTATİON OF THE MULTİPL SCLEROSİS SELF-MANAGEMENT SCALE IN TO TURKISH:VALİDTY AND RELİABİLTY STUDY (2020)
• ‘Is RLS a harbinger and consequence of MS?: Striking results of the ‘RELOMS-T’ study’ (2020)
• Ofatumumab versus Teriflunomide in Multiple Sclerosis (2020)
• Validity and Reliability Study of the Turkish Version of Multiple Sclerosis Self-Management Scale (2020)
• The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population. (2020)
• Vestibular impairment in Charcot–Marie–Tooth disease (2020)
• The decision making levels of urine tetrasaccharide for diagnosisof Pompe disease (2019)
• Aynı ailede Botulismus intoksikasyonunun farklı klinik prezantasonları (2019)
• Aynı ailede botulismus intoksikasyonunun farklı klinik prezantasyonları (2019)
• Aynı ailede Botulismus intoksikasyonunun farklı klinik prezantasonları (2019)
• Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up (2019)
• SS-77 BİR ULUSAL ÇALIŞMANIN YÖNTEMİ (ENVIROPIMS):YENİ TANI ALMIŞ ERİŞKİN, ERGEN VE ÇOCUK MULTİPLESKLEROZ(MS) OLGULARINDA OBEZİTE, SAĞLIKLIBESLENME VE FİZİKSEL AKTİVİTE DURUMUNUNARAŞTIRILMASI (2019)
• The decision making levels of urine tetrasaccharide for diagnosis of Pompe disease (2019)
• Successful Desensitisation With Alemtuzumab In A Relaps Remitting Multiple Sclerosis Case (2019)
• Aynı ailede Botulismus intoksikasyonunun farklı klinik prezantasonları (2019)
• Vestibular impairment in Charcot-Marie-Tooth disease (2019)
• Comparative analysis of fingolimod versus teriflunomide in relapsing–remitting multiple sclerosis (2019)
• Multiple Sklerozlu Hastalarda Yorgunluk ve Tedaviye Uyuma Etkisi (2019)
• Aynı ailede Botulismus intoksikasyonunun farklı klinik prezantasonları (2019)
• Sensory ataxic neuropathy with dysarthria and ophthalmoparesis: seven case reports (2019)
• Adverse effects of monoclonal antibodies in patients with multiple sclerosis: a real world experience (2019)
• Successful desensitisation with alemtuzumab in a relapse remitting multiple sclerosis case (2019)
• Urinary Symptoms in Multiple Sclerosis: Relation with Urodynamic Findings and Impact on Patient's Quality of Life (2019)
• RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the ’xxRELOMS-T’xx (2018)
• MULTİPL SKLEROZ TANILI HASTADA ALEMTUZUMAB’A BAĞLI İNFÜZYON İLİŞKİLİ REAKSİYON İLE BAŞETME-12 BASAMAKLI DESENSİTİZASYON (2018)
• Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis. (2018)
• Multiple Sklerozlu Hastalarda Hastalık Modifiye Edici İlaç Tedavisine Uyumu Etkileyen Faktörler (2018)
• CONGENITAL MYASTHENIC SYNDROMES AND MYASTHENIA (2018)
• Congenital Myasthenic Syndromes (CMS) Due to Impaired Principal Coupling Pathway in the ɛ Subunit of Muscle Acetylcholine Receptor (AChR) (P2.031) (2018)
• Let’s raise the awareness of MS specialists concerning the frequency and impact of RLS in MS and consequently the life quality of patients with MS: Striking results of the ‘RELOMS-T’ Study (P1.424) (2018)
• The effect of pilates exercise on balance, postural instability, functional capacity and quality of life in multiple sclerosis patients (2018)
• Let’s raise the awareness of MS specialistsconcerning the frequency and impact of RLS in MS and consequently the life quality ofpatients with MS: Striking results of the ‘RELOMS-T’ Study. (2018)
• Congenital Myasthenic Syndromes (CMS) Due to Impaired Principal Coupling Pathway in the. Subunit of Muscle Acetylcholine Receptor (AChR) (2018)
• Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis (2018)
• Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit (2018)
• Multiple Skleroz Ta nılı Olguda Ba şarılı Alemtuzumab Desensitizasyonu (2018)
• The effect of pilates exercise on balance, postural instability, functional capacity and quality of life in multiple sclerosis patients (2018)
• Multibl Skleroz tanılı hastalarda Alemtuzumab ile İnfüzyon ilişkili Reaksiyon ile başetme-12 basamaklı desensitizasyon (2018)
• RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the 'RELOMS-T' (2018)
• Multiple Sklerozlu Hastalarda Hastalık Modifiye Edici İlaç Tedavisine Uyumu Etkileyen Faktörler (2018)
• Translation and Validation of The Turkish Version of Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) (2018)
• Multiple Skleroz Tedaviye Uyum Anketi (The Multiple Sclerosis Treatment Adherence Questionnaire – MS-TAQ)’nin Geçerlik ve Güvenirliği Çalışması (2017)
• The Effect of Preoperative AcHR-Ab Level to the Prognosis in Operated Myasthenia Gravis patients (2017)
• MULTİPLE SKLEROZLU HASTALARDA TEDAVİ UYUMUNA ETKİ EDEN ETMENLER (2017)
• Muscle MRI findings in spinal muscular atrophy type 3 (2017)
• The validity and Reliability of the Turkish Version Of the Multiple Sclerosis Treatment Adherence Questionnaire (2017)
• Combined central and peripheral demyelination (2017)
• The effect of preoperative AchR-Ab level to the prognosis in operated myasthenia gravis patients (2017)
• Multiple sklerozlu hastalarda ilaç tedavisine uyumu engelleyen durumlar (2017)
• Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis (2017)
• Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. (2017)
• Multiple Sklerozlu Hastalarda İlaç Tedavisine Uyumu Engelleyen Durumlar (2017)
• MULTİPL SKLEROZ ARTIK HBS SEKONDER NEDENLERİ ARASINDA YERİNİ ALMALI!: BU ALANDA ŞİMDİYE KADAR YAPILMIŞ EN GENİŞ ÇAPLI ÇALIŞMANIN [MULTİPL SKLEROZUN HUZURSUZ BACAKLARI-TÜRKİYE (RELOMS-T)] ÇARPICI SONUÇLARI (2017)
• RELAPSİNG REMİTTİNG MULTİPL SKLEROZ HASTALARINDA FİNGOLİMOD GÜVENLİK VE TOLERABİLİTE VERİLERİ: EGE ÜNİVERSİTESİ MULTİPL SKLEROZ BİRİMİ DENEYİMİ (2017)

Özgeçmiş